Dublin, Nov. 07, 2017 -- The "United States Proton Therapy Market: Demand, Insights, Analysis, Opportunities, Growth Potential, and Forecast 2018 - 2025" report has been added to Research and Markets' offering.
United States Proton Therapy Market is Expected to Reach Nearly US$ 1 Billion, Potentially US$7 Billion by 2025
The report United States Proton Therapy Market: Demand, Insights, Analysis, Opportunities, Growth Potential and Forecast 2018 - 2025 examines the market dynamics, competitive landscape and discusses major trends. The study describes an in-depth analysis of the United States actual and potential proton therapy market.
Market growth can be attributed to factors such as rising cancer incidence, increasing number of proton therapy centers,decreasing cost of proton therapy treatment, technological advances and market adoption. However, high costs involved in the establishment of the center is likely to restrain growth in the forecast period.
The report concludes with the profiles of major players in the US proton therapy market. The key market players are evaluated on various parameters such as company overview, product portfolio, US proton therapy centers developed by the companies and recent development & trends of the proton therapy market.
Key Companies Covered in the Report are as follows:
- Optivus
- Hitachi
- Ion Beam Applications (IBA)
- Varian Medical Systems
- Mevion Medical Systems
Key Topics Covered:
1. Executive Summary
2. What is Proton Therapy?
3. Proton Therapy Current Applications
4. Proton Therapy Comparative Analysis
5. Market Size & Analysis: United States Proton Therapy (2012 - 2025)
6. Market Opportunity Assessment: United States Proton Therapy (2012 - 2025)
7. Key Market Drivers and Inhibitors of the United States Proton Therapy Market
8. United States Number of Treatment Rooms and Forecast (2012 - 2025)
9. United States Proton Therapy Center (Installed Base) and Treatment Room Market Share: By Company
10. United States Proton Therapy Center Infrastructure Analysis: Treatment Rooms & Proton Therapy Accelerator
11. United States Number of Patients Treated at Proton Therapy Centers (2008 - 2015)
12. United States Proton Therapy Reimbursement Scenario
13. Proton Therapy Center Component Analysis
14. Proton Therapy Clinical Trail Insight by Phase, Institute & Country
15. Proton Therapy Market - Major Deals
16. Key Companies Analysis
For more information about this report visit https://www.researchandmarkets.com/research/qqkms3/united_states
CONTACT: Research and Markets
Laura Wood, Senior Manager
[email protected]
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
Related Topics: Nuclear Medicine and Radiopharmacology


Spirit Airlines Seeks Court Approval to Auction 20 Airbus A320/A321 Aircraft Amid Bankruptcy
FAA Confirms $1.5 Billion Peraton Contract as U.S. Air Traffic Control Overhaul Accelerates
CBA Shares Surge After Record Half-Year Profit as Rate Outlook Improves
Westpac (ASX: WBC) Q1 Profit Rises 6% as Lending Growth and Treasury Income Strengthen Earnings
More U.S. Investors Join Arbitration Against South Korea Over Coupang Dispute
AbbVie Sues HHS Over Medicare Price Controls on Botox Under Inflation Reduction Act
Ancora Holdings Builds $200M Stake in Warner Bros Discovery, Targets Netflix Asset Sale Plan
How Marco Pharma International Preserves German Homeopathic Traditions in America
Novocure Stock Surges 30% After FDA Approves Optune Pax for Pancreatic Cancer Treatment
U.S. Judge Allows Jeffrey Epstein Sex Trafficking Lawsuit Against Bank of America to Proceed
Michael Kors Marks 45 Years at New York Fashion Week with Fall/Winter Collection Showcase
ByteDance Advances AI Chip Development With Samsung Manufacturing Talks
Russia Signals Further Restrictions on Telegram Amid Ongoing Regulatory Disputes
Boeing Reports Major Supply Chain Quality Improvements After Spirit AeroSystems Deal
Ralph Lauren Unveils Elegant Fall 2026 Women’s Collection Ahead of New York Fashion Week
Gates Foundation Denies Financial Ties to Jeffrey Epstein Following DOJ Email Release 



